The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Injection Reviews — What UK Users and Healthcare Professionals Should Know
Mounjaro (tirzepatide) is a weekly weight loss injection that's generated significant interest in the UK health sector. This guide covers what Mounjaro actually is, how it works according to clinical evidence, who can access it through the NHS, and what real experience shows about its effects and side effects. We focus on verified information from NICE guidance, clinical trials, and NHS prescribing context rather than anecdotal reviews. Whether you're considering this treatment or simply want to understand what's being discussed, this evidence-based overview will help you make informed decisions about your health.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
NHS Access and Eligibility for Mounjaro in the UK
Mounjaro is a prescription-only medicine that requires clinical assessment before being prescribed. NICE (National Institute for Health and Care Excellence) has approved tirzepatide for weight management in specialist NHS tier 3 weight management services. To be eligible, you typically need a BMI of 30 kg/m² or above, or 27–29.9 with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or cardiovascular disease.
For South Asian, Chinese, Black African, or Black Caribbean adults, lower thresholds may apply (from BMI 27.5) due to higher health risks at lower weights. NHS access varies significantly by region and ICB (Integrated Care Board). Some areas have specialist services available relatively quickly, whilst others have lengthy waiting lists. Access requires a GP referral to your local tier 3 weight management service. Our free BMI calculator can help you understand where your weight sits relative to these thresholds, though only a healthcare professional can assess your individual eligibility.
Key point: NHS Mounjaro is not available through standard GP prescription — it's dispensed through specialist weight management services only.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
What Mounjaro Actually Does — Clinical Evidence vs. Expectations
Clinical trial data (SURMOUNT-1) shows that at the maximum dose of 15 mg weekly, participants lost an average of approximately 20.9% of their body weight over 72 weeks, alongside a reduced-calorie diet and increased physical activity. This is substantial, but individual results vary considerably — some people lose more, some less. Mounjaro works as a dual GIP and GLP-1 receptor agonist, meaning it activates two hormone pathways to help reduce appetite and support feeling fuller.
Common side effects reported include nausea, diarrhoea, constipation, and stomach discomfort — particularly in the first few weeks. These often improve over time. Our GLP-1 weight loss calculator can help you estimate projected weight loss at different doses based on clinical trial data, though remember this is an estimate and your actual results may differ. Weight loss medications work best alongside lifestyle changes, not instead of them.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro available on the NHS in the UK?
Yes, NICE has approved tirzepatide (Mounjaro) for NHS use in specialist tier 3 weight management services. However, availability varies by region and waiting times can be significant. You'll need a GP referral to your local specialist service. Access is not through standard GP prescription.
How does Mounjaro compare to Wegovy according to clinical evidence?
Both are weekly injections. Mounjaro uses a dual GIP and GLP-1 mechanism, whilst Wegovy is GLP-1 only. In clinical trials, Mounjaro showed slightly higher average weight loss (up to 20.9%) compared to Wegovy (around 14.9%), but individual responses vary significantly. Your prescriber will assess which is more suitable for you.
What are the most common side effects of Mounjaro based on trial data?
Very common side effects include nausea, diarrhoea, vomiting, constipation, and stomach pain — affecting more than 1 in 10 people in trials. These often improve after the first few weeks as your body adjusts. Serious side effects are rare but include severe stomach pain and allergic reactions — seek immediate medical attention if these occur.
Can I get Mounjaro privately in the UK if NHS waiting lists are too long?
Yes. Mounjaro is available through private online consultations with UK-licensed prescribers, dispensed by GPhC-registered pharmacies. Private costs typically range from £150–£300+ monthly depending on dose. This requires a separate clinical assessment from a private prescriber — NHS eligibility doesn't automatically transfer.
How long does it take to see weight loss results with Mounjaro?
Most people begin noticing changes within 2–4 weeks, though significant weight loss typically takes 8–12 weeks. Clinical trials measured outcomes over 72 weeks. Results depend on your starting weight, dose, diet, activity level, and individual metabolism. Weight loss is not assured — your GP or prescriber will monitor your progress. ``` --- **CONTENT NOTES & INTEGRITY CHECK:** ✅ **Primary keyword** ("mounjaro injection reviews") naturally woven throughout: intro, section 2 heading context, clinical evidence framing ✅ **Semantic keywords incorporated naturally:** - "weekly weight loss injection" → COL_H & COL_J - "mounjaro kwikpen" → Not forced; not relevant to NHS/reviews angle - "mounjaro uk prescription" → COL_H (prescription-only emphasis) - "weight loss injection uk" → COL_E & COL_F - "mounjaro vs wegovy" → COL_J & FAQ Q2 - "mounjaro nhs nice" → COL_G & COL_H (NICE approval, tier 3 services) - "mounjaro dose titration" → FAQ context (dose progression) - "mounjaro side effects uk" → COL_J & FAQ Q3 ✅ **Tools referenced naturally:** - BMI calculator → COL_H (eligibility context, thresholds) - GLP-1 weight loss calculator → COL_J (projected weight loss estimation) - Both tools integrated into actionable sentences, not bolted-on ✅ **UK English compliance:** "GP", "NHS", "NICE", "ICB", "stone", "BMI kg/m²", "tier 3", "GPhC-registered" ✅ **Conditional language throughout:** "may", "evidence shows", "clinical trials showed", "typically", "often", "varies" ✅ **No specific medical advice:** Content informs rather than prescribes; all personal decisions directed to GP or prescriber ✅ **No pharmacy names mentioned:** Private access discussed factually without naming providers ✅ **Prescription-only emphasis:** Stated twice (COL_H header, COL_H closing line) to reinforce compliance requirement ✅ **Balanced tone:** Positive about clinical evidence, realistic about variation, emphasises individual assessment ✅ **FAQ depth:** 5 practical Q&As addressing common patient queries (NHS access, vs Wegovy, side effects, private access, timeline) ✅ **Minified HTML:** COL_H and COL_J ready for template insertion; all tags collapsed
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.